Pfizer Inc. (PFE) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Pfizer Inc. (PFE:NYSE), powered by AI.

Current Price
$26.04
P/E Ratio
19.0
Market Cap
148.0B
Sector
Healthcare
What is the Pfizer Inc. stock price forecast?

Pfizer Inc. is currently trading at $26.04. View real-time AI analysis on Alpha Lenz.

What is Pfizer Inc. insider trading activity?

View the latest insider trading data for Pfizer Inc. on Alpha Lenz.

What is Pfizer Inc.'s P/E ratio?

Pfizer Inc.'s P/E ratio is 19.0.

Pfizer Inc.

NYSE · PFE
$26.04+0.04(+0.15%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Pfizer Inc.'s future dividend policy...
Alpha Chat Insight

Pfizer Inc. trades at a P/E of 19.0 (fair value) with solid ROE of 8.9%. Operating margin of 25.2% indicates strong profitability.

Ask for details

Company Overview

Pfizer Inc. is a multinational pharmaceutical and biotechnology corporation, recognized for its role in the research, development, and manufacturing of healthcare products. Operating in the health sector, Pfizer focuses on creating innovative medicines and vaccines that significantly improve patients' lives. It is renowned for its contributions to pivotal health areas, such as oncology, immunology, cardiovascular health, and rare diseases. Pfizer maintains a robust pipeline of products at various stages of clinical development, enhancing its market position and impact. The company is instrumental in the global pharmaceutical landscape, contributing to public health with breakthroughs like vaccines and therapies that tackle some of the world's most challenging diseases. Headquartered in New York City, Pfizer plays a critical role in addressing urgent medical needs worldwide and is involved in extensive collaborations with scientific communities and healthcare systems. As a key player in the pharmaceutical industry, Pfizer’s developments and strategic initiatives can influence market trends and health policies, underscoring its importance in the global effort to combat health issues.

CEODr. Albert Bourla D.V.M., Ph.D.
SectorHealthcare
IndustryDrug Manufacturers - General
Employees81,000

Company Statistics

FY 2025

Profile

$147.99BMarket Cap
$62.58BRevenue
0.00Shares Out
81,000Employees

Margins

74.33%Gross
38.56%EBITDA
25.24%Operating
12.02%Pre-Tax
12.48%Net

Valuation

19.04P/E
1.71P/B
2.36EV/Sales
8.75EV/EBITDA
16.31P/FCF

Growth (CAGR)

-14.56%Rev 3Yr
8.48%Rev 5Yr
-24.89%Op Inc 3Yr
12.34%Op Inc 5Yr
-37.11%Net Inc 3Yr
-3.21%Net Inc 5Yr

Returns

3.71%ROA
8.90%ROE
4.83%ROIC

Financial Health

$1.14BCash & Cash Equivalents
$120.24BNet Debt
139.88%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Pfizer Inc. (ticker: PFE) is a company listed on NYSE in the Healthcare sector (Drug Manufacturers - General). It has approximately 81,000 employees. Market cap is $148.0B.

The current price is $26.04 with a P/E ratio of 19.04x and P/B of 1.71x.

ROE is 8.90% and operating margin is 25.24%. Annual revenue is $62.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Pfizer Inc. (PFE) Stock Forecast 2026 $26.04 — Price, Financials & Analyst Targets | Alpha Lenz